Janssen, Arrowhead partner to develop HBV RNA interference therapy https://t.co/SdbyUHur2L
— Marisa Peer (@PeerMarisa) October 4, 2018
https://platform.twitter.com/widgets.js
from Twitter https://twitter.com/PeerMarisa
October 04, 2018 at 10:30AM
Janssen, Arrowhead partner to develop HBV RNA interference therapy https://t.co/SdbyUHur2L
— Marisa Peer (@PeerMarisa) October 4, 2018
https://platform.twitter.com/widgets.js
from Twitter https://twitter.com/PeerMarisa
October 04, 2018 at 10:30AM